Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Why the Teva Pharmaceuticals Stock Rebound May Be Real | InvestorPlace
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Capital Research Global Investors increases ownership in TEVJF / Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Stock Could Double | Barron's
TEVA Pharmaceuticals sells Forest facility to private investor | WSET
Teva Pharmaceuticals Portfolio Investments, Teva Pharmaceuticals Funds, Teva Pharmaceuticals Exits
Jewish Values Investors JLens Target Israeli Company
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
Teva Reports Earnings Tomorrow. Here's What to Expect. | Barron's
Teva Pharmaceutical Industries Adds US$389m To Market Cap, But Investors Still Down 47% From Five Years Ago - Simply Wall St News
Teva dispenses $2.6 million to resolve ERISA claims | Pensions & Investments
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily
Teva Pharmaceutical Industries — 9 Portfolio companies, 10 Investments, Team — Unicorn Nest
Teva Pharmaceuticals - Wikipedia
Industrial Investor Pays $24M for Teva's Irvine Campus - Orange County Business Journal
Buy Teva Pharmaceuticals amid positive news, Bernstein says
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA) | Seeking Alpha
